Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
83.1M
-
Number of holders
-
84
-
Total 13F shares, excl. options
-
64M
-
Shares change
-
-10.8M
-
Total reported value, excl. options
-
$77.4M
-
Value change
-
-$23.5M
-
Put/Call ratio
-
8.44
-
Number of buys
-
45
-
Number of sells
-
-55
-
Price
-
$1.21
Significant Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 per share (ACET) as of Q2 2024
117 filings reported holding ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 per share as of Q2 2024.
Adicet Bio, Inc. - Common Stock, par value $0.0001 per share (ACET) has 84 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64M shares
of 83.1M outstanding shares and own 76.99% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (11.4M shares), TANG CAPITAL MANAGEMENT LLC (8.22M shares), RA CAPITAL MANAGEMENT, L.P. (7.54M shares), GOLDMAN SACHS GROUP INC (4.28M shares), MILLENNIUM MANAGEMENT LLC (3.62M shares), VANGUARD GROUP INC (3.1M shares), Carlyle Group Inc. (2.95M shares), Aquilo Capital Management, LLC (2.53M shares), RENAISSANCE TECHNOLOGIES LLC (1.51M shares), and Blackstone Inc. (1.24M shares).
This table shows the top 84 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.